Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-Prosper HF: Probenecid in HFrEF
NCT04551222Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jun 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of probenecid in heart failure with reduced ejection fraction (HFrEF), sponsored by VA Office of Research & Development. Started Jun 2021; status: completed.
02
Drugs
probenecid
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT04551222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04551222.